Investor Relations

Corporate Information

Principal Place of Business in China and Registered Office

Principal Place of Business in China: 5th Floor, Shuyu Building, 98 Wenyi West Road, Xihu District, Hangzhou, China
Registered Office: Cricket Square, Hutchins Drive P.O. Box 2681 Grand Cayman, KY1- 1111 Cayman Islands

Principal Place of Business in Hong Kong

31/F, Tower Two, Times Square 1 Matheson Street Causeway Bay Hong Kong

Corporate Governance

Audit Committee

We established an audit committee on April 17th, 2019 with written terms of reference in compliance with Rule 3.21 of the Listing Rules and the Corporate Governance Code as set out in Appendix 14 to the Listing Rules.

The audit committee consists of three members, being Mr. Kam Wai Man, Dr. Ou-Yang Hui and Dr. Gao Fuping. Mr. Kam Wai Man has been appointed as the chairman of the audit committee, and is an INED possessing the appropriate professional qualifications.

The primary duties of the audit committee are to provide our Directors with an independent review of the effectiveness of the financial reporting process, internal control and risk management system of our Group, to oversee the audit process and to perform other duties and responsibilities as assigned by our Directors.

Remuneration Committee

We established a remuneration committee on April 17th, 2019 with written terms of reference in compliance with Rule 3.25 of the Listing Rules and the Corporate Governance Code as set out in Appendix 14 to the Listing Rules.

The remuneration committee consists of four members, being Dr. Ou-Yang Hui, Dr. Gao Fuping, Mr. Kam Wai Man and Mr. Zhu Jiangbo. Dr. Ou-Yang Hui, an INED, has been appointed as the chairman of the remuneration committee.

The primary duties of the remuneration committee include, amongst others, the following matters: making recommendations to our Directors on our policy and structure for remunerations of all our Directors and senior management and on the establishment of a formal and transparent procedure for developing policies on such remuneration, determining the terms of the specific remuneration package of our Directors and senior management, and reviewing and approving performance-based remuneration by reference to corporate goals and objectives resolved by our Directors from time to time.

Nomination Committee

We established a nomination committee on April 17th, 2019 with written terms of reference in compliance with the Corporate Governance Code as set out in Appendix 14 to the Listing Rules.

The nomination committee comprises four members, being Mr. Chen Xiaoliang, Dr. Ou-Yang Hui, Dr. Gao Fuping and Mr. Kam Wai Man. Mr. Chen Xiaoliang has been appointed as the chairman of our nomination committee.

The primary duties of the nomination committee are to make recommendations to our Directors on all new appointments of Directors and senior management, interviewing nominees,to take up references and to consider related matters.

Announcements and Circulars

即将开通

Prospectus

Corporate Presentations

Analyst Coverage

招银国际CMB International Securities Limited

Sophie Huang

sophiehuang@cmbi.com.hk

Address: 45/F, Champion Tower, 3 Garden Road, Hong Kong

凯基证券KGI

Christopher Ho

christopher.ho@kgi.com

Address:41/F Central Plaza, 18 Harbour Road, Wanchai, Hong Kong

海通证券

周旭辉

zxh12382@htsec.com

张向伟

zxw10402@htsec.com

新华汇富Sunwah Kingsway

Ingrid He

Ingrid.he@sunwahkingsway.com

Hugo Suen

Hugo.suen@sunwahkingsway.com

Steven Nie

Steven.nie@sunwahkingsway.com

中银国际BOCI

Jamie SHEN

jamiec.shen@bocigroup.com

Cleo ZHANG

cleojd.zhang@bocigroup.com

Michael MENG

michael.meng@bocigroup.com

Address:20/F, Bank of China Tower 1 Garden Road

Hong Kong

Tel: (852) 3988 6000

Investor Relations Contacts

Duiba Limited

Tel: 0571-28258680

Address: 5th Floor, Shuyu Building, 98 Wenyi West Road, Xihu District, Hangzhou, China

Email: ir@duiba.com.cn